▶ 調査レポート

ヒト正常免疫グロブリンの世界市場2020年:メーカー別、地域別、種類・用途別

• 英文タイトル:Global Human Normal Immunoglobulin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

GlobalInfoResearchが調査・発行した産業分析レポートです。ヒト正常免疫グロブリンの世界市場2020年:メーカー別、地域別、種類・用途別 / Global Human Normal Immunoglobulin Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025 / D0GIR-06246資料のイメージです。• レポートコード:D0GIR-06246
• 出版社/出版日:GlobalInfoResearch / 2020年9月18日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、107ページ
• 納品方法:Eメール
• 産業分類:医療、製薬、バイオ
• 販売価格(消費税別)
  Single User¥515,040 (USD3,480)▷ お問い合わせ
  Multi User¥772,560 (USD5,220)▷ お問い合わせ
  Corporate User¥1,030,080 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
本調査レポートでは、ヒト正常免疫グロブリンの世界市場を広く調査・分析し、今後の市場展望をまとめております。ヒト正常免疫グロブリンの種類別市場規模(B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他)、用途別市場規模(政府機関、民間部門、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・市場概要
・メーカー情報(販売量、市場シェア、製品概要、SWOT分析):CSL Behring、CNBG、Kedrion、Grifols、Kamada、Biotest、Shanghai RAAS、Emergent (Cangene)、CBPO、Hualan Bio、Sichuan Yuanda Shuyang、ADMA Biologics
・地域別グローバル市場分析 2015年-2020年
・ヒト正常免疫グロブリンの北米市場(アメリカ、カナダ、メキシコ)
・ヒト正常免疫グロブリンのヨーロッパ市場(ドイツ、イギリス、フランス、ロシア、イタリア)
・ヒト正常免疫グロブリンのアジア市場(中国、日本、韓国、インド、東南アジア、オーストラリア)
・ヒト正常免疫グロブリンの南米市場(ブラジル、アルゼンチン)
・ヒト正常免疫グロブリンの中東・アフリカ市場(サウジアラビア、トルコ、エジプト、南アフリカ)
・種類別分析:B型肝炎免疫グロブリン、狂犬病免疫グロブリン、破傷風免疫グロブリン、その他
・用途別分析:政府機関、民間部門、その他
・地域別市場規模予測 2021年-2025年
・販売チャネル、流通業者、代理店
・調査の結果・結論

Market Overview
The Human Normal Immunoglobulin market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

The most likely (base case) scenario is that the global Human Normal Immunoglobulin sales will be xx in 2020 from Human Normal Immunoglobulin million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global Human Normal Immunoglobulin market size is expected to grow at xx% or more annually for the next five years.

This report also researches and evaluates the impact of Covid-19 outbreak on the Human Normal Immunoglobulin industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on Human Normal Immunoglobulin and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).

Market segmentation
Human Normal Immunoglobulin market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Human Normal Immunoglobulin market has been segmented into
Hepatitis B Immunoglobulins
Rabies Immunoglobulins
Tetanus Immunoglobulins
Others

By Application, Human Normal Immunoglobulin has been segmented into:
Government Institutions
Private Sector
Other

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Human Normal Immunoglobulin market presented in the report. This section sheds light on the sales growth of different regional and country-level Human Normal Immunoglobulin markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Human Normal Immunoglobulin market.

The report offers in-depth assessment of the growth and other aspects of the Human Normal Immunoglobulin market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Human Normal Immunoglobulin Market Share Analysis
Human Normal Immunoglobulin competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Human Normal Immunoglobulin sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Human Normal Immunoglobulin sales, revenue and market share for each player covered in this report.

The major players covered in Human Normal Immunoglobulin are:
CSL Behring
CNBG
Kedrion
Grifols
Kamada
Biotest
Shanghai RAAS
Emergent (Cangene)
CBPO
Hualan Bio
Sichuan Yuanda Shuyang
ADMA Biologics

Among other players domestic and global, Human Normal Immunoglobulin market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Human Normal Immunoglobulin product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Human Normal Immunoglobulin, with price, sales, revenue and global market share of Human Normal Immunoglobulin in 2018 and 2019.
Chapter 3, the Human Normal Immunoglobulin competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Human Normal Immunoglobulin breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Human Normal Immunoglobulin market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Human Normal Immunoglobulin sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

1 Market Overview
1.1 Human Normal Immunoglobulin Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Human Normal Immunoglobulin Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Hepatitis B Immunoglobulins
1.2.3 Rabies Immunoglobulins
1.2.4 Tetanus Immunoglobulins
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Human Normal Immunoglobulin Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Government Institutions
1.3.3 Private Sector
1.3.4 Other
1.4 Overview of Global Human Normal Immunoglobulin Market
1.4.1 Global Human Normal Immunoglobulin Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
1.6 COVID-19 Outbreak: Human Normal Immunoglobulin Industry Impact
1.6.1 COVID-19 Potential Implications for the Human Normal Immunoglobulin
1.6.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on Human Normal Immunoglobulin
1.6.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.6.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.6.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.6.2 Opportunity Analysis in Covid-19 Crisis
1.6.3 Market Risk and Restraints
1.6.4 Market Driving Force
2 Manufacturers Profiles
2.1 CSL Behring
2.1.1 CSL Behring Details
2.1.2 CSL Behring Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 CSL Behring SWOT Analysis
2.1.4 CSL Behring Product and Services
2.1.5 CSL Behring Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 CNBG
2.2.1 CNBG Details
2.2.2 CNBG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 CNBG SWOT Analysis
2.2.4 CNBG Product and Services
2.2.5 CNBG Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Kedrion
2.3.1 Kedrion Details
2.3.2 Kedrion Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Kedrion SWOT Analysis
2.3.4 Kedrion Product and Services
2.3.5 Kedrion Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Grifols
2.4.1 Grifols Details
2.4.2 Grifols Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Grifols SWOT Analysis
2.4.4 Grifols Product and Services
2.4.5 Grifols Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Kamada
2.5.1 Kamada Details
2.5.2 Kamada Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Kamada SWOT Analysis
2.5.4 Kamada Product and Services
2.5.5 Kamada Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Biotest
2.6.1 Biotest Details
2.6.2 Biotest Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Biotest SWOT Analysis
2.6.4 Biotest Product and Services
2.6.5 Biotest Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Shanghai RAAS
2.7.1 Shanghai RAAS Details
2.7.2 Shanghai RAAS Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Shanghai RAAS SWOT Analysis
2.7.4 Shanghai RAAS Product and Services
2.7.5 Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Emergent (Cangene)
2.8.1 Emergent (Cangene) Details
2.8.2 Emergent (Cangene) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Emergent (Cangene) SWOT Analysis
2.8.4 Emergent (Cangene) Product and Services
2.8.5 Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.9 CBPO
2.9.1 CBPO Details
2.9.2 CBPO Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 CBPO SWOT Analysis
2.9.4 CBPO Product and Services
2.9.5 CBPO Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.10 Hualan Bio
2.10.1 Hualan Bio Details
2.10.2 Hualan Bio Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 Hualan Bio SWOT Analysis
2.10.4 Hualan Bio Product and Services
2.10.5 Hualan Bio Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.11 Sichuan Yuanda Shuyang
2.11.1 Sichuan Yuanda Shuyang Details
2.11.2 Sichuan Yuanda Shuyang Major Business and Total Revenue (Financial Highlights) Analysis
2.11.3 Sichuan Yuanda Shuyang SWOT Analysis
2.11.4 Sichuan Yuanda Shuyang Product and Services
2.11.5 Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.12 ADMA Biologics
2.12.1 ADMA Biologics Details
2.12.2 ADMA Biologics Major Business and Total Revenue (Financial Highlights) Analysis
2.12.3 ADMA Biologics SWOT Analysis
2.12.4 ADMA Biologics Product and Services
2.12.5 ADMA Biologics Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Human Normal Immunoglobulin Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Human Normal Immunoglobulin Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Human Normal Immunoglobulin Manufacturer Market Share in 2019
3.3.2 Top 6 Human Normal Immunoglobulin Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Human Normal Immunoglobulin Sales, Revenue and Market Share by Regions
4.1.1 Global Human Normal Immunoglobulin Sales and Market Share by Regions (2015-2020)
4.1.2 Global Human Normal Immunoglobulin Revenue and Market Share by Regions (2015-2020)
4.2 North America Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.3 Europe Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.5 South America Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
5.1.1 North America Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
5.1.2 North America Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
5.2 United States Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5.3 Canada Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
5.4 Mexico Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
6.1.1 Europe Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
6.1.2 Europe Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
6.2 Germany Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.3 UK Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.4 France Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.5 Russia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
6.6 Italy Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Human Normal Immunoglobulin Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Human Normal Immunoglobulin Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Human Normal Immunoglobulin Revenue and Market Share by Regions (2015-2020)
7.2 China Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.3 Japan Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.4 Korea Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.5 India Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
7.7 Australia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
8.1.1 South America Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
8.1.2 South America Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
8.2 Brazil Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
8.3 Argentina Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Human Normal Immunoglobulin Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Human Normal Immunoglobulin Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Human Normal Immunoglobulin Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.3 Turkey Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.4 Egypt Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
9.5 South Africa Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Human Normal Immunoglobulin Sales and Market Share by Type (2015-2020)
10.2 Global Human Normal Immunoglobulin Revenue and Market Share by Type (2015-2020)
10.3 Global Human Normal Immunoglobulin Price by Type (2015-2020)
11 Global Human Normal Immunoglobulin Market Segment by Application
11.1 Global Human Normal Immunoglobulin Sales Market Share by Application (2015-2020)
11.2 Global Human Normal Immunoglobulin Revenue Market Share by Application (2015-2020)
11.3 Global Human Normal Immunoglobulin Price by Application (2015-2020)
12 Market Forecast
12.1 Global Human Normal Immunoglobulin Sales, Revenue and Growth Rate (2021-2025)
12.2 Human Normal Immunoglobulin Market Forecast by Regions (2021-2025)
12.2.1 North America Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.2 Europe Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.3 Asia-Pacific Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.4 South America Human Normal Immunoglobulin Market Forecast (2021-2025)
12.2.5 Middle East & Africa Human Normal Immunoglobulin Market Forecast (2021-2025)
12.3 Human Normal Immunoglobulin Market Forecast by Type (2021-2025)
12.3.1 Global Human Normal Immunoglobulin Sales Forecast by Type (2021-2025)
12.3.2 Global Human Normal Immunoglobulin Market Share Forecast by Type (2021-2025)
12.4 Human Normal Immunoglobulin Market Forecast by Application (2021-2025)
12.4.1 Global Human Normal Immunoglobulin Sales Forecast by Application (2021-2025)
12.4.2 Global Human Normal Immunoglobulin Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables
Table 1. Global Human Normal Immunoglobulin Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Human Normal Immunoglobulin by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Human Normal Immunoglobulin Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Human Normal Immunoglobulin Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. CSL Behring Basic Information, Manufacturing Base and Competitors
Table 9. CSL Behring Human Normal Immunoglobulin Major Business
Table 10. CSL Behring Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 11. CSL Behring SWOT Analysis
Table 12. CSL Behring Human Normal Immunoglobulin Product and Services
Table 13. CSL Behring Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. CNBG Basic Information, Manufacturing Base and Competitors
Table 15. CNBG Human Normal Immunoglobulin Major Business
Table 16. CNBG Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 17. CNBG SWOT Analysis
Table 18. CNBG Human Normal Immunoglobulin Product and Services
Table 19. CNBG Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Kedrion Basic Information, Manufacturing Base and Competitors
Table 21. Kedrion Human Normal Immunoglobulin Major Business
Table 22. Kedrion Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 23. Kedrion SWOT Analysis
Table 24. Kedrion Human Normal Immunoglobulin Product and Services
Table 25. Kedrion Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Grifols Basic Information, Manufacturing Base and Competitors
Table 27. Grifols Human Normal Immunoglobulin Major Business
Table 28. Grifols Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 29. Grifols SWOT Analysis
Table 30. Grifols Human Normal Immunoglobulin Product and Services
Table 31. Grifols Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Kamada Basic Information, Manufacturing Base and Competitors
Table 33. Kamada Human Normal Immunoglobulin Major Business
Table 34. Kamada Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 35. Kamada SWOT Analysis
Table 36. Kamada Human Normal Immunoglobulin Product and Services
Table 37. Kamada Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Biotest Basic Information, Manufacturing Base and Competitors
Table 39. Biotest Human Normal Immunoglobulin Major Business
Table 40. Biotest Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 41. Biotest SWOT Analysis
Table 42. Biotest Human Normal Immunoglobulin Product and Services
Table 43. Biotest Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 45. Shanghai RAAS Human Normal Immunoglobulin Major Business
Table 46. Shanghai RAAS Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 47. Shanghai RAAS SWOT Analysis
Table 48. Shanghai RAAS Human Normal Immunoglobulin Product and Services
Table 49. Shanghai RAAS Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Emergent (Cangene) Basic Information, Manufacturing Base and Competitors
Table 51. Emergent (Cangene) Human Normal Immunoglobulin Major Business
Table 52. Emergent (Cangene) Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 53. Emergent (Cangene) SWOT Analysis
Table 54. Emergent (Cangene) Human Normal Immunoglobulin Product and Services
Table 55. Emergent (Cangene) Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 56. CBPO Basic Information, Manufacturing Base and Competitors
Table 57. CBPO Human Normal Immunoglobulin Major Business
Table 58. CBPO Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 59. CBPO SWOT Analysis
Table 60. CBPO Human Normal Immunoglobulin Product and Services
Table 61. CBPO Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 62. Hualan Bio Basic Information, Manufacturing Base and Competitors
Table 63. Hualan Bio Human Normal Immunoglobulin Major Business
Table 64. Hualan Bio Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 65. Hualan Bio SWOT Analysis
Table 66. Hualan Bio Human Normal Immunoglobulin Product and Services
Table 67. Hualan Bio Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 68. Sichuan Yuanda Shuyang Basic Information, Manufacturing Base and Competitors
Table 69. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Major Business
Table 70. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 71. Sichuan Yuanda Shuyang SWOT Analysis
Table 72. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Product and Services
Table 73. Sichuan Yuanda Shuyang Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 74. ADMA Biologics Basic Information, Manufacturing Base and Competitors
Table 75. ADMA Biologics Human Normal Immunoglobulin Major Business
Table 76. ADMA Biologics Human Normal Immunoglobulin Total Revenue (USD Million) (2018-2019)
Table 77. ADMA Biologics SWOT Analysis
Table 78. ADMA Biologics Human Normal Immunoglobulin Product and Services
Table 79. ADMA Biologics Human Normal Immunoglobulin Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 80. Global Human Normal Immunoglobulin Sales by Manufacturer (2018-2019) (K Units)
Table 81. Global Human Normal Immunoglobulin Revenue by Manufacturer (2018-2019) (USD Million)
Table 82. Global Human Normal Immunoglobulin Sales by Regions (2015-2020) (K Units)
Table 83. Global Human Normal Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 84. Global Human Normal Immunoglobulin Revenue by Regions (2015-2020) (USD Million)
Table 85. North America Human Normal Immunoglobulin Sales by Countries (2015-2020) (K Units)
Table 86. North America Human Normal Immunoglobulin Sales Market Share by Countries (2015-2020)
Table 87. North America Human Normal Immunoglobulin Revenue by Countries (2015-2020) (USD Million)
Table 88. North America Human Normal Immunoglobulin Revenue Market Share by Countries (2015-2020)
Table 89. Europe Human Normal Immunoglobulin Sales by Countries (2015-2020) (K Units)
Table 90. Europe Human Normal Immunoglobulin Sales Market Share by Countries (2015-2020)
Table 91. Europe Human Normal Immunoglobulin Revenue by Countries (2015-2020) (USD Million)
Table 92. Asia-Pacific Human Normal Immunoglobulin Sales by Regions (2015-2020) (K Units)
Table 93. Asia-Pacific Human Normal Immunoglobulin Sales Market Share by Regions (2015-2020)
Table 94. Asia-Pacific Human Normal Immunoglobulin Revenue by Regions (2015-2020) (USD Million)
Table 95. South America Human Normal Immunoglobulin Sales by Countries (2015-2020) (K Units)
Table 96. South America Human Normal Immunoglobulin Sales Market Share by Countries (2015-2020)
Table 97. South America Human Normal Immunoglobulin Revenue by Countries (2015-2020) (USD Million)
Table 98. South America Human Normal Immunoglobulin Revenue Market Share by Countries (2015-2020)
Table 99. Middle East & Africa Human Normal Immunoglobulin Sales by Countries (2015-2020) (K Units)
Table 100. Middle East & Africa Human Normal Immunoglobulin Sales Market Share by Countries (2015-2020)
Table 101. Middle East & Africa Human Normal Immunoglobulin Revenue by Countries (2015-2020) (USD Million)
Table 102. Middle East & Africa Human Normal Immunoglobulin Revenue Market Share by Countries (2015-2020)
Table 103. Global Human Normal Immunoglobulin Sales by Type (2015-2020) (K Units)
Table 104. Global Human Normal Immunoglobulin Sales Share by Type (2015-2020)
Table 105. Global Human Normal Immunoglobulin Revenue by Type (2015-2020) (USD Million)
Table 106. Global Human Normal Immunoglobulin Revenue Share by Type (2015-2020)
Table 107. Global Human Normal Immunoglobulin Sales by Application (2015-2020) (K Units)
Table 108. Global Human Normal Immunoglobulin Sales Share by Application (2015-2020)
Table 109. Global Human Normal Immunoglobulin Sales Forecast by Regions (2021-2025) (K Units)
Table 110. Global Human Normal Immunoglobulin Market Share Forecast by Regions (2021-2025)
Table 111. Global Human Normal Immunoglobulin Sales Forecast by Type (2021-2025) (K Units)
Table 112. Global Human Normal Immunoglobulin Market Share Forecast by Type (2021-2025)
Table 113. Global Human Normal Immunoglobulin Sales Forecast by Application (2021-2025)
Table 114. Global Human Normal Immunoglobulin Market Share Forecast by Application (2021-2025)
Table 115. Direct Channel Pros & Cons
Table 116. Indirect Channel Pros & Cons
Table 117. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Human Normal Immunoglobulin Picture
Figure 2. Global Sales Market Share of Human Normal Immunoglobulin by Type in 2019
Figure 3. Hepatitis B Immunoglobulins Picture
Figure 4. Rabies Immunoglobulins Picture
Figure 5. Tetanus Immunoglobulins Picture
Figure 6. Others Picture
Figure 7. Human Normal Immunoglobulin Sales Market Share by Application in 2018
Figure 8. Government Institutions Picture
Figure 9. Private Sector Picture
Figure 10. Other Picture
Figure 11. Global Human Normal Immunoglobulin Market Status and Outlook (2015-2025) (USD Million)
Figure 12. United States Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Canada Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Mexico Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Germany Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 16. France Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 17. UK Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Russia Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Italy Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 20. China Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Japan Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Korea Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 23. India Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Southeast Asia Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Australia Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 26. Brazil Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Egypt Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Saudi Arabia Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 29. South Africa Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Turkey Human Normal Immunoglobulin Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Global Human Normal Immunoglobulin Sales Market Share by Manufacturer in 2019
Figure 32. Global Human Normal Immunoglobulin Revenue Market Share by Manufacturer in 2019
Figure 33. Top 3 Human Normal Immunoglobulin Manufacturer (Revenue) Market Share in 2019
Figure 34. Top 6 Human Normal Immunoglobulin Manufacturer (Revenue) Market Share in 2019
Figure 35. Key Manufacturer Market Share Trend
Figure 36. Global Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 37. Global Human Normal Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 38. Global Human Normal Immunoglobulin Revenue Market Share by Regions (2015-2020)
Figure 39. Global Human Normal Immunoglobulin Revenue Market Share by Regions in 2018
Figure 40. North America Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 41. Europe Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 42. Asia-Pacific Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 43. South America Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 44. Middle East & Africa Human Normal Immunoglobulin Sales and Growth Rate (2015-2020)
Figure 45. North America Human Normal Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 46. North America Human Normal Immunoglobulin Sales Market Share by Countries (2015-2020)
Figure 47. North America Human Normal Immunoglobulin Sales Market Share by Countries in 2018
Figure 48. North America Human Normal Immunoglobulin Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 49. North America Human Normal Immunoglobulin Revenue Market Share by Countries in 2018
Figure 50. United States Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Canada Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Mexico Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Europe Human Normal Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 54. Europe Human Normal Immunoglobulin Revenue Market Share by Countries (2015-2020)
Figure 55. Europe Human Normal Immunoglobulin Revenue Market Share by Countries in 2019
Figure 56. Germany Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 57. UK Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 58. France Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Russia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Italy Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Asia-Pacific Human Normal Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 62. Asia-Pacific Human Normal Immunoglobulin Sales Market Share by Regions 2019
Figure 63. Asia-Pacific Human Normal Immunoglobulin Revenue Market Share by Regions 2019
Figure 64. China Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Japan Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Korea Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 67. India Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 68. Southeast Asia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 69. South America Human Normal Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 70. South America Human Normal Immunoglobulin Sales Market Share by Countries in 2019
Figure 71. South America Human Normal Immunoglobulin Revenue Market Share by Countries in 2019
Figure 72. Brazil Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Argentina Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Middle East and Africa Human Normal Immunoglobulin Revenue and Growth Rate (2015-2020) (USD Million)
Figure 75. Middle East and Africa Human Normal Immunoglobulin Sales Market Share by Countries in 2019
Figure 76. Middle East and Africa Human Normal Immunoglobulin Revenue Market Share by Countries (2015-2020)
Figure 77. Middle East and Africa Human Normal Immunoglobulin Revenue Market Share by Countries in 2019
Figure 78. Saudi Arabia Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Egypt Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Turkey Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 81. South Africa Human Normal Immunoglobulin Sales and Growth Rate (2015-2020) (K Units)
Figure 82. Global Human Normal Immunoglobulin Sales and Growth Rate (2021-2025) (K Units)
Figure 83. Global Human Normal Immunoglobulin Revenue and Growth Rate (2021-2025) (USD Million)
Figure 84. North America Sales Human Normal Immunoglobulin Market Forecast (2021-2025) (K Units)
Figure 85. Europe Sales Human Normal Immunoglobulin Market Forecast (2021-2025) (K Units)
Figure 86. Asia-Pacific Sales Human Normal Immunoglobulin Market Forecast (2021-2025) (K Units)
Figure 87. South America Sales Human Normal Immunoglobulin Market Forecast (2021-2025) (K Units)
Figure 88. Middle East & Africa Sales Human Normal Immunoglobulin Market Forecast (2021-2025) (K Units)
Figure 89. Sales Channel: Direct Channel vs Indirect Channel